Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pfister

Showing results (241-250 of 288) with videos related to

Pageof 29
Sort By:
JAMA Network Open|June 2, 2023
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled TrialNancy Y Lee, Jonathan Harris, John Kim, et al.
The New England Journal of Medicine|February 15, 2013
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancerAlan L Ho, Ravinder K Grewal, Rebecca Leboeuf, et al.
International Journal of Cancer|February 26, 2013
Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancerAnuj Goenka, Luc G T Morris, Shyam S Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancerRazelle Kurzrock, Steven I Sherman, Douglas W Ball, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2017
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateArlene A Forastiere, Nofisat Ismaila, Jan S Lewin, et al.
Science (New York, N.Y.)|November 18, 2006
The impact of boreal forest fire on climate warmingJ T Randerson, H Liu, M G Flanner, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2010
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experienceJeremy Setton, Nicola Caria, Jonathan Romanyshyn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 29, 2024
Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell-Like CarcinomaChristopher A Febres-Aldana, Mahmoud M Elsayad, Maelle Saliba, et al.
Thyroid : Official Journal of the American Thyroid Association|January 20, 2022
Enhancing Radioiodine Incorporation in <i>BRAF</i>-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical TrialVatche Tchekmedyian, Lara Dunn, Eric Sherman, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2011
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomesBenjamin H Lok, Jeremy Setton, Nicola Caria, et al.
Pageof 29

Showing results (241-250 of 288) with videos related to

Sort By:
Pageof 29
JAMA Network Open|June 2, 2023
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled TrialNancy Y Lee, Jonathan Harris, John Kim, et al.
The New England Journal of Medicine|February 15, 2013
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancerAlan L Ho, Ravinder K Grewal, Rebecca Leboeuf, et al.
International Journal of Cancer|February 26, 2013
Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancerAnuj Goenka, Luc G T Morris, Shyam S Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancerRazelle Kurzrock, Steven I Sherman, Douglas W Ball, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2017
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateArlene A Forastiere, Nofisat Ismaila, Jan S Lewin, et al.
Science (New York, N.Y.)|November 18, 2006
The impact of boreal forest fire on climate warmingJ T Randerson, H Liu, M G Flanner, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2010
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experienceJeremy Setton, Nicola Caria, Jonathan Romanyshyn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 29, 2024
Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell-Like CarcinomaChristopher A Febres-Aldana, Mahmoud M Elsayad, Maelle Saliba, et al.
Thyroid : Official Journal of the American Thyroid Association|January 20, 2022
Enhancing Radioiodine Incorporation in <i>BRAF</i>-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical TrialVatche Tchekmedyian, Lara Dunn, Eric Sherman, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2011
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomesBenjamin H Lok, Jeremy Setton, Nicola Caria, et al.
Pageof 29